Search the Newsreel

PROCEPT BioRobotics Corporation Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased shares between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT misled investors regarding its handpiece sales …

Patriot Acquisition Corp. (PTAC) posts Q2 2026 profit on $176.6M Trust

Patriot Acquisition Corp. (PTAC), a Cayman Islands blank check company, reported a Q2 2026 net income of $167,713, primarily driven by $728,239 in interest income from its $176.6 million Trust Account. The company, which completed its IPO in May 2026, aims to complete a …

COPT Defense Declares Third Quarter 2026 Common Dividend

Publishes 2026 Corporate Sustainability Report and TCFD Report COLUMBIA, Md., August 13, 2026--(BUSINESS WIRE)--COPT Defense Properties (NYSE: CDP) ("COPT Defense" or the "Company") announced today that its Board of Trustees declared a regular quarterly dividend of $0.32 per common share for the third quarter …

Credit Acceptance Corporation (CACC): Neary reports 6.3% stake via trust on Schedule 13G/A

John P. Neary, as co-trustee of the Marital Trust U/A Donald A. Foss Trust, has reported a beneficial ownership of 652,797 shares of Credit Acceptance Corporation (CACC) common stock. This stake represents 6.3% of the company's outstanding shares, with all voting and dispositive authority …

Credit Acceptance Named One of PEOPLE Magazine’s 100 Companies That Care® for Fifth Consecutive Year

Credit Acceptance Corporation has been recognized by PEOPLE Magazine and Great Place To Work® as one of the 100 Companies That Care® for the fifth consecutive year, ranking 11th. The company's CEO, Vinayak Hegde, highlighted their commitment to treating people with respect and making …

COPT Defense declares $0.32 quarterly dividend, releases reports

COPT Defense Properties (NYSE:CDP) has declared a quarterly dividend of $0.32 per common share, payable on October 15, 2026, to shareholders of record on September 30, 2026. The company also released its twelfth annual Corporate Sustainability Report and fifth annual Task Force on Climate-Related …

Precision Optics (POCI) CFO acquires 1,257 shares via stock compensation plan

Precision Optics Corporation, Inc. CFO Wayne M. Coll acquired 1,257 shares of common stock on June 30, 2026, at $4.972 per share as a grant/award. This transaction is part of an Employment Agreement allowing up to $25,000 per year of compensation to be paid …

World Acceptance Corp (WRLD) SVP of Information Technology Jason Childers Sells 2,000 Shares

Jason Childers, SVP of Information Technology at World Acceptance Corp (WRLD), sold 2,000 shares for approximately $381,480. This sale contributes to a pattern of insider selling over the past year, with no insider buys recorded. Despite the insider selling and the stock being deemed …

OptimizeRx (OPRX) revenue falls 21% as margins and cash flow hold

OptimizeRx (OPRX) reported a significant revenue decline of 21% year-to-date and 30% in Q2 2026, primarily due to the wind-down of a low-margin managed service program and the loss of revenue from a key customer. Despite this, the company improved its gross margin by …

Aptiv (APTV) CEO Kevin Clark makes bona fide gift of 51,190 shares

Aptiv PLC CEO Kevin P. Clark reported a bona fide gift of 51,190 Ordinary Shares on August 12, 2026. This transaction was a non-cash transfer with a stated price of $0.00 per share. Following the gift, Clark directly holds 599,826 Ordinary Shares and indirectly …

Indaptus Therapeutics Releases Q2 2026 Financial Results

Indaptus Therapeutics (INDP) reported its Q2 2026 financial results, with a basic and diluted EPS of -$0.02, which represents a significant narrowing of losses compared to Q2 2025. The biotechnology company posted a net loss of $1.8 million for the quarter. Analyst consensus for …

World Acceptance SVP Jason Childers sells $381,480 in shares

PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy

PTC Therapeutics has won a bankruptcy auction for Sangamo Therapeutics' gene therapy candidate, isaralgagene civaparvovec (ST-920), for Fabry disease, with a bid of $111 million upfront and up to $100 million in milestone payments. This acquisition expands PTC's rare disease pipeline, bringing a therapy …

JonesTrading Forecasts Strong Price Appreciation for Septerna (NASDAQ:SEPN) Stock

World Acceptance Corp (WRLD) SVP Jason Childers sells 2,000 shares

World Acceptance Corp's Senior Vice President of Information Technology, Jason E. Childers, sold 2,000 shares of common stock on August 12, 2026, at $190.74 per share. This transaction, totaling $381,000, leaves him with 12,799 shares directly held. The sale was reported in a Form …

PTC Inc. stock outperforms competitors on strong trading day

PTC Inc. (PTC) stock gained 3.99% to $153.89 on Thursday, outperforming the broader market indices like the S&P 500 and Dow Jones Industrial Average. This rise ended a two-day losing streak for the company's shares. The strong performance occurred on a positive trading day …

Credit Acceptance Corp (CACC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Credit Acceptance Corp (CACC), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows a neutral signal based on technical indicators but strong buy signals from moving averages. The analysis helps investors …

Sarepta Therapeutics (SRPT) sees 5.05% ownership reported by AQR in 13G/A

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5,329,691 shares, or 5.05%, of Sarepta Therapeutics, Inc. common stock as of June 30, 2026. This reported amount includes 1,004,002 shares represented by Convertible Notes. Both entities share …

SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 - PRCT

Brand Concepts Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Optimum Communications (OPTU) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Sarah Freedman Chairman and Chief Executive Officer - Dennis Mathew Chief Financial Officer - Marc Sirota Full Conference Call Transcript Operator: Good …

Stifel cuts OptimizeRx stock price target on revenue headwinds

Stifel has lowered its price target for OptimizeRx (NASDAQ: OPRX) to $12 from $14, while maintaining a Buy rating, due to significant revenue headwinds. The company reported a 30% year-over-year revenue decline in Q2 2026, though adjusted earnings per share exceeded expectations. OptimizeRx reiterated …

AirSculpt Technologies, Inc. Just Missed Earnings; Here's What Analysts Are Forecasting Now

AirSculpt Technologies (NASDAQ: AIRS) shares dropped 34% after missing second-quarter revenue predictions and reporting a statutory loss. Analysts have since increased loss per share expectations for 2026 and significantly cut the average price target, signaling concerns about growing losses and slower revenue growth compared …

Massachusetts Biotech's Flagship Gene Therapy Posts Fifth Straight Quarterly Decline as Muscular Dystrophy Data Loom

Sarepta Therapeutics (SRPT) saw its flagship gene therapy, ELEVIDYS, experience a fifth consecutive quarterly revenue decline, with analysts from H.C. Wainwright & Co. reiterating a Sell rating and a $5.00 price target. Despite this, the market reaction was muted, suggesting investors are assigning significant …

Credit Acceptance names former Amazon AI executive as CTO

Credit Acceptance Corporation announced the appointment of Jeetu Mirchandani, a former Amazon AI executive, as its new Chief Technology Officer, effective August 27, 2026. Mirchandani brings over two decades of technology leadership from Amazon, where he specialized in applied AI, supply chain technology, personalization, …

Credit Acceptance Announces New Chief Technology Officer to Advance Digital-First, AI-Enabled Business Evolution

Credit Acceptance Corporation (CACC) has appointed Jeetu Mirchandani as its new Chief Technology Officer, effective August 27, 2026. Mirchandani, with over two decades of leadership experience at Amazon, will spearhead the company's engineering and technology strategy, focusing on accelerating its digital-first, AI-enabled evolution. This …

PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who suffered losses exceeding $100K to secure counsel before the September 22, 2026, lead plaintiff deadline. The firm reminds purchasers of PRCT common stock between February 28, 2024, and February 25, …

Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against AdaptHealth Corp. (AHCO) after the company reported significantly lower-than-expected Q2 2026 revenue and adjusted EBITDA, along with a substantial reduction in full-year guidance. The firm encourages investors who purchased AdaptHealth securities to connect with …

Amazon’s Applied AI Head Will Join Credit Acceptance Aug. 27

Credit Acceptance (Nasdaq: CACC) has appointed Jeetu Mirchandani, a veteran technology and AI executive from Amazon, as its new Chief Technology Officer, effective August 27, 2026. Mirchandani will lead the company's Engineering organization and technology strategy to accelerate its digital-first, AI-enabled evolution. His extensive …

Indaptus Therapeutics Q2 EPS beats estimate as loss narrows

Dickson Concepts says U.K. Harvey Nichols sale will not affect Hong Kong operations

PTC Advances Leadership in AI-Driven Design with Launch of Onshape FeatureScript MCP Server

Enables engineers to create reusable custom CAD features using natural language and AI, no programming experience required Automates feature development through AI-assisted building, testing, debugging, and refinement Captures engineering knowledge as reusable CAD automation that can be shared across teams without ongoing AI interactions …

Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary

Indaptus Therapeutics, Inc. reported a significant improvement in its financial results for the second quarter of 2026, with a net loss of $(1.79M) and EPS of $(0.02), primarily due to reduced R&D and G&A spending following the wind-down of its Decoy20 Phase 1 study. …

Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise

Indaptus Therapeutics (INDP) significantly reduced its operating expenses and net loss in Q2 2026, bolstering its cash reserves with a $12 million private placement. The company reported an 83% drop in R&D costs and a narrowed net loss of $1.8 million, while it evaluates …

Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2

Indaptus Therapeutics (INDP) significantly reduced its net loss in Q2 2026 to $1.8 million from $5.2 million in the previous year, primarily due to an 83% cut in R&D and a 37% decline in G&A expenses as it halted its Decoy20 clinical program and …

PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy

PTC Therapeutics (PTCT) is acquiring ST-920, a BLA-stage Fabry gene therapy, from Sangamo Therapeutics for $111 million upfront and up to $100 million in milestones. This acquisition aims to expand PTC's rare disease portfolio and facilitate accelerated FDA approval by late 2026, with a …